Works by Basso, Ana M.

Results: 6

Structural abnormalities revealed by magnetic resonance imaging in rats prenatally exposed to methylazoxymethanol acetate parallel cerebral pathology in schizophrenia.

Published in:

Synapse, 2011, v. 65, n. 5, p. 393, doi. 10.1002/syn.20857

By:

CHIH-LIANG CHIN;
CURZON, PETER;
SCHWARTZ, ANNETTE J.;
O'CONNOR, ELIZABETH M.;
RUETER, LYNNE E.;
FOX, GERARD B.;
DAY, MARK;
BASSO, ANA M.

Publication type:

Article

Preclinical evaluation of non-imidazole histamine H3 receptor antagonists in comparison to atypical antipsychotics for the treatment of cognitive deficits associated with schizophrenia.

Published in:

International Journal of Neuropsychopharmacology, 2013, v. 16, n. 4, p. 889, doi. 10.1017/S1461145712000739

By:

Brown, Jordan W.;
Basso, Ana M.;
Rueter, Lynne E.;
Min Zhang

Publication type:

Article

Antidepressant-Like Effect of D2/3 Receptor-, but not D4 Receptor-Activation in the Rat Forced Swim Test.

Published in:

Neuropsychopharmacology, 2005, v. 30, n. 7, p. 1257, doi. 10.1038/sj.npp.1300677

By:

Basso, Ana M;
Gallagher, Kelly B;
Bratcher, Natalie A;
Brioni, Jorge D;
Moreland, Robert B;
Hsieh, Gin C;
Drescher, Karla;
Fox, Gerard B;
Decker, Michael W;
Rueter, Lynne E

Publication type:

Article

eIF2B activator prevents neurological defects caused by a chronic integrated stress response.

Published in:

eLife, 2019, p. 1, doi. 10.7554/eLife.42940

By:

Yao Liang Wong;
LeBon, Lauren;
Basso, Ana M.;
Kohlhaas, Kathy L.;
Nikkel, Arthur L.;
Robb, Holly M.;
Donnelly-Roberts, Diana L.;
Prakash, Janani;
Swensen, Andrew M.;
Rubinstein, Nimrod D.;
Krishnan, Swathi;
McAllister, Fiona E.;
Haste, Nicole V.;
O’Brien, Jonathon J.;
Roy, Margaret;
Ireland, Andrea;
Frost, Jennifer M.;
Lei Shi;
Riedmaier, Stephan;
Martin, Kathleen

Publication type:

Article

The drug-induced helplessness test: an animal assay for assessing behavioral despair in response to neuroleptic treatment.

Published in:

Psychopharmacology, 2007, v. 190, n. 1, p. 1, doi. 10.1007/s00213-006-0577-y

By:

Ballard, Michael E.;
Basso, Ana M.;
Gallagher, Kelly B.;
Browman, Kaitlin E.;
Fox, Gerard B.;
Drescher, Karla U.;
Gross, Gerhard;
Decker, Michael W.;
Rueter, Lynne E.;
Min Zhang

Publication type:

Article

Corticotropin-releasing factor antagonist attenuates the "anxiogenic-like" effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats.

Published in:

Psychopharmacology, 1999, v. 145, n. 1, p. 21, doi. 10.1007/s002130051028

By:

Basso, Ana M.;
Spina, Mariarosa;
Rivier, Jean;
Vale, Wylie;
Koob, George F.

Publication type:

Article

Works by Basso, Ana M.

Structural abnormalities revealed by magnetic resonance imaging in rats prenatally exposed to methylazoxymethanol acetate parallel cerebral pathology in schizophrenia.

Preclinical evaluation of non-imidazole histamine H<sub>3</sub> receptor antagonists in comparison to atypical antipsychotics for the treatment of cognitive deficits associated with schizophrenia.

Antidepressant-Like Effect of D<sub>2/3</sub> Receptor-, but not D<sub>4</sub> Receptor-Activation in the Rat Forced Swim Test.

eIF2B activator prevents neurological defects caused by a chronic integrated stress response.

The drug-induced helplessness test: an animal assay for assessing behavioral despair in response to neuroleptic treatment.

Corticotropin-releasing factor antagonist attenuates the "anxiogenic-like" effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats.